位置：成果数据库 > 期刊 > 期刊详情页
Emerging drugs for idiopathic thrombocytopenic purpura in adults
  • ISSN号：1472-8214
  • 期刊名称：Expert Opinion on Emerging Drugs
  • 时间：0
  • 页码：237-254
  • 语言：英文
  • 相关项目：TLR7/BlyS/TRAFs信号传导途径在ITP发病中的分子机制研究
作者： Li, Xiaofang|Hou, Ming|
同期刊论文项目
TLR7/BlyS/TRAFs信号传导途径在ITP发病中的分子机制研究
期刊论文 40 会议论文 2 获奖 3 著作 3
同项目期刊论文
靛玉红诱导免疫性血小板减少性紫癜小鼠免疫耐受机制的研究
BAFF - an essential survival factor for B cells: Links to genesis of ITP and may be of therapeutic t
Modulation of immune response with cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin-induce
Targeting the Notch signaling pathway in autoimmune diseases
The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia
人源化抗血小板膜糖蛋白VI单链抗体的研究
High-dose dexamethasone regulates interleukin-18 and interleukin-18 binding protein in idiopathic th
Evaluation of gross tumor size using CT, F-18-FDG PET, integrated F-18-FDG PET/CT and pathological a
慢性淋巴细胞白血病间期荧光原位杂交检测染色体异常及临床分析
间期荧光原位杂交检测多发性骨髓瘤并临床分析
Imatinib achieved complete cytogenetic response in a CML patient received 32-year indirubin and its
多肿瘤标志物蛋白芯片检测系统在临床应用中的评价
山东省首例β海洋性贫血特征家系报道——附文献复习
EMP3 Overexpression in Primary Breast Carcinomas is not Associated with Epigenetic Aberrations
De novo induction of platelet-specific CD4(+)CD25(+) regulatory T cells from CD4(+)CD25(-) cells in
特发性血小板减少性紫癜的规范化诊断
特发性血小板减少性紫癜的发病机制
小分子干扰RNA联合反义脱氧寡核苷酸靶向逆转人乳腺癌细胞MCF-7/ADR多药耐药的研究
短发夹RNA干扰表达质粒逆转人乳腺癌细胞MCF-7/ADR多药耐药的研究
糖皮质激素耐药特发性血小板减少性紫癜治疗进展
成人特发性血小板减少性紫癜的规范化诊断与治疗
Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-smal
Effects of rhubarb extract on radiation induced lung toxicity via decreasing transforming growth fac
A case of Philadelphia-chromosome positive chronic idiopathic myelofibrosis
抗核抗体对大剂量地塞米松治疗成人特发性血小板减少性紫癜的临床意义
IL-18及其受体在特发性血小板减少性紫癜患者Th1类细胞优势应答中的作用
血小板膜表面自身抗体表达与大剂量地塞米松治疗ITP疗效的关系
免疫性血小板减少症患者外周血白细胞介素-18及其受体α链的表达
前瞻性评价单克隆抗体俘获血小板抗原技术对免疫性血小板减少症的诊断价值